Eur J Hosp Pharm. 2019 Nov;26(6):334-338. doi: 10.1136/ejhpharm-2017-001476. Epub 2018 May 30.

Validation of the LESS-CHRON criteria: reliability study of a tool for deprescribing in patients with multimorbidity.

European journal of hospital pharmacy : science and practice

Aitana Rodríguez-Pérez, Eva Rocío Alfaro-Lara, María Isabel Sierra-Torres, Ángela Villalba-Moreno, María Dolores Nieto-Martin, Mercedes Galván-Banqueri, Bernardo Santos-Ramos

PMID: 31798857 PMCID: PMC6855848 DOI: 10.1136/ejhpharm-2017-001476

Abstract

OBJECTIVE: The 'LESS-CHRON criteria' (List of Evidence-Based Deprescribing for Chronic Patients criteria) is a newly created tool with 27 criteria to guide deprescribing. It was developed using a Delphi methodology. Each criterion consists of drugs and their indications, conditions under which deprescribing would be considered, a health variable to be monitored after deprescribing and a follow-up period. The aim of our study was to evaluate the reliability of the LESS-CHRON criteria in a population of patients with multimorbidity to determine the possible usefulness of this tool in clinical practice.

METHODS: We selected chronic patients with multimorbidity from an internal medicine unit who were older than 80 years old and were alive at the time of the study. To determine interobserver reliability, each professional (internist or hospital pharmacy specialist) applied the questionnaire under the same conditions and with the same resources. To determine intraobserver reliability, each health professional applied the tool at baseline and 2 months later. We measured interobserver and intraobserver reliability using the kappa coefficient. The proportion of overall agreement was also determined.

RESULTS: We obtained a moderate overall kappa (ĸ=0.46, 95% CI 0.36 to 0.55) for interobserver reliability, and good (ĸ=0.65, 95% CI 0.57 to 0.78) and moderate (ĸ=0.59, 95% CI 0.49 to 0.74) values for intraobserver reliability for the internist and pharmacist, respectively. The proportion of overall agreement was very high: 92% (range: 62%-100%) for the interobserver, and 94% (80%-100%) and 93% (63%-100%) for the internist and pharmacist, respectively.

CONCLUSIONS: The LESS-CHRON criteria shows early promise as a reliable method to help guide deprescribing in patients with multimorbidity. Further, more complete testing with a larger sample of prescribers is needed.

© European Association of Hospital Pharmacists 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Keywords: appropriateness; deprescribing; multimorbidity; polypharmacy; reliability

Conflict of interest statement

References

1. J Am Geriatr Soc. 1975 Oct;23(10):433-41 - PubMed
2. Expert Opin Drug Saf. 2014 Jan;13(1):57-65 - PubMed
3. JAMA. 2005 Aug 10;294(6):716-24 - PubMed
4. Eur J Intern Med. 2015 Sep;26(7):e18-9 - PubMed
5. Geriatr Gerontol Int. 2017 Nov;17(11):2200-2207 - PubMed
6. Arch Gerontol Geriatr. 2010 Sep-Oct;51(2):185-91 - PubMed
7. J Gen Intern Med. 2007 Dec;22 Suppl 3:391-5 - PubMed
8. Ann Fam Med. 2003 May-Jun;1(1):15-21 - PubMed
9. JAMA Intern Med. 2015 May;175(5):827-34 - PubMed
10. Int J Clin Pharmacol Ther. 2008 Feb;46(2):72-83 - PubMed
11. Eur J Intern Med. 2012 Sep;23(6):506-12 - PubMed
12. Arch Intern Med. 2002 Nov 11;162(20):2269-76 - PubMed
13. Age Ageing. 2009 Sep;38(5):603-6 - PubMed
14. Eur J Intern Med. 2013 Jul;24(5):420-4 - PubMed
15. Qual Life Res. 2006 Feb;15(1):83-91 - PubMed
16. J Clin Epidemiol. 1990;43(6):551-8 - PubMed
17. Intern Med J. 2015 Mar;45(3):352-6 - PubMed
18. Md State Med J. 1965 Feb;14:61-5 - PubMed
19. BMJ Open. 2016 Mar 24;6(3):e010989 - PubMed
20. Support Care Cancer. 2015 Jan;23(1):71-8 - PubMed
21. Ageing Res Rev. 2011 Sep;10(4):430-9 - PubMed
22. Phys Ther. 2005 Mar;85(3):257-68 - PubMed
23. Ann Fam Med. 2005 May-Jun;3(3):223-8 - PubMed
24. Ann Pharmacother. 2009 Jul;43(7):1239-44 - PubMed
25. Eur J Intern Med. 2011 Jun;22(3):311-7 - PubMed
26. BMJ. 2007 May 19;334(7602):1016-7 - PubMed

Publication Types

• Journal Article